EUVIMEDEUVIMED entdecken
Crossref

Bergamottin, A Natural Bioactive Compound, Inhibits Dabie Bandavirus Infection In Vitro and In Vivo

Yi Wan, Wenting Mao iD, Yang Liu, Wei Deng, Yuxia Hou, Wei Wang

Journal of Medical Virology · 2025-07 · 97 (7)

DOI: 10.1002/jmv.70495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 17.07.2025. Verfasst von Yi Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. Hauptthemen laut MEDLINE: Antiviral Agents, Furocoumarins, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: This work was supported by the National Key Research and Development Program of China (2022YFC2303300, 2023YFC2605504), the National Natural Science Foundation….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe fever with thrombocytopenia syndrome (SFTS) is a novel, highly fatal disease caused by Dabie bandavirus (DBV), also referred to as severe fever with thrombocytopenia syndrome virus (SFTSV). DBV is endemic to many Asian countries, and its incidence has recently increased. However, there are currently no specific therapies for combating DBV infection. Here we verified whether the natural bioactive compound, bergamottin, effectively inhibits DBV in vitro and in vivo. A primary in vitro study suggested that bergamottin suppressed DBV infection both in Vero E6 and Huh‐7 cells in a dose‐dependent manner. Time‐of‐addition assay revealed that bergamottin interferes with DBV infection at multiple stages of the viral life cycle. Moreover, bergamottin inhibits viral internalization and effectively reduces viral genome replication. The efficacy of bergamottin at doses of 75 and 120 mg/kg/d against DBV infection in an IFNAR −/− mouse infection model was investigated. Oral delivery at a dose of 120 mg/kg/d significantly reduced the number of the viral RNA copies in the kidneys, spleen, and lungs. These findings highlight that bergamottin is a promising agent that could be further developed as a therapeutic agent against DBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsFurocoumarinsPhlebovirusSevere Fever with Thrombocytopenia SyndromeAnimalsMiceHumansChlorocebus aethiopsVirus ReplicationVirus InternalizationDisease Models, AnimalVero CellsCell Line

Stichwörter der Autor:innen

Dabie bandavirusantiviralbergamottinsevere fever with thrombocytopenia syndrome

Substanzen

Antiviral AgentsFurocoumarins

Autor:innen und Institutionen

  • State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • University of the Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Wenting Mao

Förderung

  • This work was supported by the National Key Research and Development Program of China (2022YFC2303300, 2023YFC2605504), the National Natural Science Foundation…

Zitieren

APA

Wan, Y., Mao, W., Liu, Y., Deng, W., Hou, Y., & Wang, W. (2025). Bergamottin, A Natural Bioactive Compound, Inhibits Dabie Bandavirus Infection In Vitro and In Vivo. Journal of Medical Virology, 97(7). https://doi.org/10.1002/jmv.70495

Vancouver

Wan Y, Mao W, Liu Y, Deng W, Hou Y, Wang W. Bergamottin, A Natural Bioactive Compound, Inhibits Dabie Bandavirus Infection In Vitro and In Vivo. Journal of Medical Virology. 2025;97(7). doi:10.1002/jmv.70495

BibTeX
@article{Wan2025,
  author = {Wan, Yi and Mao, Wenting and Liu, Yang and Deng, Wei and Hou, Yuxia and Wang, Wei},
  title = {Bergamottin, A Natural Bioactive Compound, Inhibits Dabie Bandavirus Infection In Vitro and In Vivo},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {7},
  doi = {10.1002/jmv.70495}
}
Kostenlos starten →